4.4 Article

Increased incidence of meningococcal disease in HIV-infected individuals associated with higher case-fatality ratios in South Africa

Journal

AIDS
Volume 24, Issue 9, Pages 1351-1360

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/QAD.0b013e32833a2520

Keywords

bacteremia; HIV; meningitis; meningococcus; mortality; Neisseria meningitidis; serogroup; South Africa; surveillance

Funding

  1. United States Agency for International Development's Antimicrobial Resistance Initiative
  2. Centers for Disease Control and Prevention (CDC), Atlanta, Georgia [U60/CCU022088]
  3. National Center for HIV/AIDS
  4. Viral Hepatitis, STD
  5. TB Prevention (NCHHSTP)
  6. Global AIDS Program (GAP) Cooperative Agreement [U62/PSO022901]

Ask authors/readers for more resources

Objectives: We aimed to compare the incidence of meningococcal disease amongst HIV-infected and uninfected individuals and to evaluate whether HIV is a risk factor for mortality and bacteremia amongst patients with meningococcal disease. Design: Cohort surveillance study. Methods: We conducted laboratory-based surveillance for meningococcal disease in Gauteng Province, South Africa. HIV status and outcome data were obtained at sentinel sites. Incidence in HIV-infected and uninfected persons was calculated assuming a similar age-specific HIV prevalence in tested and untested individuals. Risk factors for death and bacteremia (as compared with meningitis) were evaluated using multivariable logistic regression. Results: From 2003 to 2007, 1336 meningococcal cases were reported. Of 504 patients at sentinel sites with known outcome, 308 (61%) had HIV serostatus data. HIV prevalence amongst cases of meningococcal disease was higher than the population HIV prevalence in all age groups. The incidence of meningococcal disease in HIV-infected individuals was elevated in all age groups with an age-adjusted relative risk of 11.3 [95% confidence interval (CI) 8.9-14.3, P<0.001]. The case-fatality ratio (CFR) was 20% (27/138) amongst HIV-infected and 11% (18/170) amongst HIV-uninfected individuals [odds ratio (OR) 2.1, 95% CI 1.1-3.9]. On multivariable analysis, CFR was greater amongst patients with bacteremia (35%, 29/82) compared with meningitis (7%, 16/226) (OR 7.8, 95% CI 3.4-17.7). HIV infection was associated with increased odds of bacteremia (OR 2.7, 95% CI 1.5-5.0). Conclusion: HIV-infected individuals may be at increased risk of meningococcal disease. The increased CFR in HIV-infected patients may be explained by their increased odds of bacteremia compared to meningitis. (C) 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Medicine, General & Internal

Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa

Mihaly Koltai, Jocelyn Moyes, Bryan Nyawanda, Joyce Nyiro, Patrick K. Munywoki, Stefano Tempia, Xiao Li, Marina Antillon, Joke Bilcke, Stefan Flasche, Philippe Beutels, D. James Nokes, Cheryl Cohen, Mark Jit

Summary: Respiratory syncytial virus (RSV) causes a significant burden of acute lower respiratory infection in children under 5 years, especially in low- and middle-income countries. Maternal vaccine (MV) and next-generation monoclonal antibody (mAb) candidates have shown effectiveness in reducing RSV disease. Original hospital-based data from South Africa and Kenya suggest that interventions against RSV disease may be more cost-effective than previously estimated.

BMC MEDICINE (2023)

Article Medicine, General & Internal

The burden of RSV-associated illness in children aged < 5 years, South Africa, 2011 to 2016

Jocelyn Moyes, Stefano Tempia, Sibongile Walaza, Meredith L. McMorrow, Florette Treurnicht, Nicole Wolter, Anne von Gottberg, Kathleen Kahn, Adam L. Cohen, Halima Dawood, Ebrahim Variava, Cheryl Cohen

Summary: Based on a study in South African children, the burden of RSV-associated illness was estimated, with newborns and infants being the most affected group. Implementing maternal vaccination and monoclonal antibody products for this group can help reduce the disease burden.

BMC MEDICINE (2023)

Article Medicine, General & Internal

The economic burden of RSV-associated illness in children aged < 5 years, South Africa 2011-2016

Jocelyn Moyes, Stefano Tempia, Sibongile Walaza, Meredith L. McMorrow, Florette Treurnicht, Nicole Wolter, Anne von Gottberg, Kathleen Kahn, Adam L. Cohen, Halima Dawood, Ebrahim Variava, Cheryl Cohen

Summary: Studying the economic burden of RSV-associated illness can help inform decisions on the implementation of maternal vaccines and monoclonal antibodies. A costing study conducted in South Africa estimated the cost of RSV-associated illness in infants and found that the highest cost burden was in the youngest infants.

BMC MEDICINE (2023)

Article Infectious Diseases

A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participants

Waasila Jassat, Caroline Mudara, Caroline Vika, Richard Welch, Tracy Arendse, Murray Dryden, Lucille Blumberg, Natalie Mayet, Stefano Tempia, Arifa Parker, Jeremy Nel, Rubeshan Perumal, Michelle J. Groome, Francesca Conradie, Norbert Ndjeka, Louise Sigfrid, Laura Merson, Cheryl Cohen

Summary: The study aimed to describe the prevalence of and risk factors for post-COVID-19 condition (PCC). A total of 46.7% of hospitalized and 18.5% of nonhospitalized participants experienced >= 1 symptoms at 6 months. Risk factors for PCC included older age, female sex, non-Black race, presence of a comorbidity, greater number of acute COVID-19 symptoms, hospitalization/COVID-19 severity, and wave period.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

Editorial Material Medicine, General & Internal

COVID-19 infection, reinfection, and the transition to endemicity

Cheryl Cohen, Juliet Pulliam

LANCET (2023)

Article Infectious Diseases

Epidemiology and susceptibility of Nakaseomyces (formerly Candida) glabrata bloodstream isolates from hospitalised adults in South Africa

Serisha D. Naicker, Liliwe Shuping, Thokozile G. Zulu, Ruth S. Mpembe, Mabatho Mhlanga, Ernest M. Tsotetsi, Tsidiso G. Maphanga, Nelesh P. Govender, GERMS SA

Summary: Nakaseomyces glabrata is a common cause of candidaemia in South Africa, particularly in older female patients admitted to public hospitals and post-surgery patients. Many of these patients are treated with suboptimal doses of fluconazole, and a small percentage of N. glabrata isolates show resistance to echinocandins and fluconazole. Echinocandins or polyenes are recommended for the treatment of confirmed N. glabrata candidaemia.

MEDICAL MYCOLOGY (2023)

Editorial Material Biochemistry & Molecular Biology

When to update COVID-19 vaccine composition

Rebecca Grant, Jilian A. Sacks, Priya Abraham, Supamit Chunsuttiwat, Cheryl Cohen, J. Peter Figueroa, Thomas Fleming, Paul Fine, David Goldblatt, Hideki Hasegawa, C. Raina MacIntrye, Ziad A. Memish, Elizabeth Miller, Sergio Nishioka, Amadou A. Sall, Samba Sow, Oyewale Tomori, Youchun Wang, Maria D. Van Kerkhove, Marie-Ange Wambo, Homa Attar Cohen, Samuel Mesfin, James R. Otieno, Lorenzo Subissi, Sylvie Briand, David E. Wentworth, Kanta Subbarao

Summary: Vaccines for different SARS-CoV-2 variants have been authorized, but continuous monitoring is necessary to decide when vaccine antigen composition should be revised, along with clinical studies to assess vaccine effectiveness.

NATURE MEDICINE (2023)

Article Multidisciplinary Sciences

Optimal age targeting for pneumococcal vaccination in older adults; a modelling study

Deus Thindwa, Samuel Clifford, Jackie Kleynhans, Anne von Gottberg, Sibongile Walaza, Susan Meiring, Todd D. Swarthout, Elizabeth Miller, Peter McIntyre, Nick Andrews, Zahin Amin-Chowdhury, Norman Fry, Kondwani C. Jambo, Neil French, Samanta Cristine Grassi Almeida, Shamez N. Ladhani, Robert S. Heyderman, Cheryl Cohen, Maria Cristina de Cunto Brandileone, Stefan Flasche

Summary: The risk of invasive pneumococcal disease (IPD) increases with age for older adults, but the population benefiting from pneumococcal vaccines and the immunogenic response to vaccination decline. This study examined the impact of demographics, vaccine efficacy, and waning efficacy on the optimal age for pneumococcal vaccination. The findings suggest that administering pneumococcal vaccines earlier in adulthood in low/middle-income countries could prevent a significant proportion of residual IPD burden.

NATURE COMMUNICATIONS (2023)

Article Infectious Diseases

TNFAIP3-interacting protein 1 polymorphisms and their association with symptomatic human respiratory syncytial virus infection and bronchiolitis in infants younger than one year from South Africa: A case-control study

Maria Martin-Vicente, Hloni Mthiyane, Maria A. Jimenez-Sousa, Kathleen Subramoney, Orienka Hellferscee, Nicole Wolter, Sibongile Walaza, Amanda Fernandez-Rodriguez, Cheryl Cohen, Anne von Gottberg, Salvador Resino, Isidoro Martinez, Florette K. Treurnicht

Summary: The TNIP1 gene polymorphisms are associated with the susceptibility to symptomatic HRSV infection and bronchiolitis in infants, particularly the rs73272842 G allele and rs999011 C allele.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

Article Infectious Diseases

The attributable fraction of respiratory syncytial virus among patients of different ages with influenza-like illness and severe acute respiratory illness in a high HIV prevalence setting, South Africa, 2012-2016

Jocelyn Moyes, Stefano Tempia, Sibongile Walaza, Meredith L. McMorrow, Adam L. Cohen, Florette Treurnicht, Orienka Hellferscee, Nicole Wolter, Anne Von Gottberg, Halima Dawood, Ebrahim Variava, Kathleen Kahn, Shabir A. Madhi, Cheryl Cohen

Summary: This study aimed to calculate the attributable fraction (AF) of respiratory syncytial virus (RSV) in clinical syndromes across different age groups. Using logistic regression models, the AF of RSV-associated influenza-like illness (ILI) and severe acute respiratory illness (SARI) cases were estimated by comparing RSV detection prevalence among cases and healthy controls in South Africa from 2012-2016. The results showed significant associations between RSV and ILI and SARI cases, particularly in younger age groups.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

Article Multidisciplinary Sciences

Healthcare utilization during the first two waves of the COVID-19 epidemic in South Africa: A cross-sectional household survey

Nicole Wolter, Stefano Tempia, Anne von Gottberg, Jinal N. Bhiman, Sibongile Walaza, Jackie Kleynhans, Jocelyn Moyes, Sue Aitken, Sarah Magni, Jessica Yun, Tamika Fellows, Tetelo Makamadi, Renay Weiner, Cherie Cawood, Neil Martinson, Limakatso Lebina, Cheryl Cohen

Summary: This study investigated healthcare utilization in the catchment areas of healthcare facilities in three provinces during the COVID-19 pandemic. The findings showed that less than half of ILI cases and only 71% of SRI cases received medical care during the first two waves of COVID-19 in South Africa. This suggests that facility-based surveillance data may underestimate the burden of COVID-19.

PLOS ONE (2023)

Article Biology

Association of close-range contact patterns with SARS-CoV-2: a household transmission study

Jackie Kleynhans, Lorenzo Dall'Amico, Laetitia Gauvin, Michele Tizzoni, Lucia Maloma, Sibongile Walaza, Neil A. Martinson, Anne von Gottberg, Nicole Wolter, Mvuyo Makhasi, Cheryl Cohen, Ciro Cattuto, Stefano Tempia

Summary: This study deployed proximity sensors in South African households and found no association between close-range contact events and SARS-CoV-2 transmission. The findings may be attributed to study limitations or the high contact rates within households.

ELIFE (2023)

No Data Available